Released Mar 31, 2014, after the close
10-K filed Mar 31, 2014, 90 days after period end · 0001144204-14-019383
Q4 2013 · 10-K
derived · Computed from the longer spans the company filed.
Revenue—
Net Income-$6.05M-$6.05M derivedN/M vs Q4 2012N/M vs Q3 2013
EPS, diluted—Not derived. Share counts vary by quarter.
Operating Incomederived-$6,094,044N/M
Free Cash Flowderived-$5,393,743—
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2013dderived from reported figures | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Net Income | -$6.05M | -$3.79M | -$18.86M | — |
| EPS Diluted | — | -$0.29 | -$1.52 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Assembly Biosciences, Inc. · CIK 1426800 · Engraved from SEC EDGAR